Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 251

1.

A review of human vaccine research and development: malaria.

Girard MP, Reed ZH, Friede M, Kieny MP.

Vaccine. 2007 Feb 19;25(9):1567-80. Epub 2006 Oct 5. Review.

PMID:
17045367
2.

The promise of asexual malaria vaccine development.

Pasloske BL, Howard RJ.

Am J Trop Med Hyg. 1994;50(4 Suppl):3-10. Review.

PMID:
8172329
3.

The immunological challenge to developing a vaccine to the blood stages of malaria parasites.

Good MF, Stanisic D, Xu H, Elliott S, Wykes M.

Immunol Rev. 2004 Oct;201:254-67. Review.

PMID:
15361246
4.

Emerging rules for subunit-based, multiantigenic, multistage chemically synthesized vaccines.

Patarroyo ME, Patarroyo MA.

Acc Chem Res. 2008 Mar;41(3):377-86. doi: 10.1021/ar700120t. Epub 2008 Feb 12. Review.

PMID:
18266328
6.

Vaccinating with the genome: a Sisyphean task?

Coppel RL.

Trends Parasitol. 2009 May;25(5):205-12. doi: 10.1016/j.pt.2009.02.006. Epub 2009 Apr 7.

PMID:
19359219
7.

Malaria vaccines: are we getting closer?

Epstein JE, Giersing B, Mullen G, Moorthy V, Richie TL.

Curr Opin Mol Ther. 2007 Feb;9(1):12-24. Review.

PMID:
17330398
8.

Overview: immunology of malaria and progress in malaria vaccine development.

Tharavanij S.

Southeast Asian J Trop Med Public Health. 1992 Sep;23 Suppl 4:71-87. Review. No abstract available.

PMID:
1364871
9.

Progress in the development of recombinant and synthetic blood-stage malaria vaccines.

Mahanty S, Saul A, Miller LH.

J Exp Biol. 2003 Nov;206(Pt 21):3781-8. Review.

10.

Development of the RTS,S/AS malaria candidate vaccine.

Vekemans J, Leach A, Cohen J.

Vaccine. 2009 Dec 30;27 Suppl 6:G67-71. doi: 10.1016/j.vaccine.2009.10.013.

PMID:
20006143
11.

Development of vaccines against malaria.

Berzins K.

Int J Immunopharmacol. 1994 May-Jun;16(5-6):385-90. Review.

PMID:
7927983
12.

Plasmodium falciparum serine repeat antigen 5 (SE36) as a malaria vaccine candidate.

Palacpac NM, Arisue N, Tougan T, Ishii KJ, Horii T.

Vaccine. 2011 Aug 11;29(35):5837-45. doi: 10.1016/j.vaccine.2011.06.052. Epub 2011 Jun 28. Review.

PMID:
21718740
13.

Progress towards the development of malaria vaccines.

Malkin E, Dubovsky F, Moree M.

Trends Parasitol. 2006 Jul;22(7):292-5. Epub 2006 May 16.

PMID:
16707275
14.

Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles.

Lalitha PV, Biswas S, Pillai CR, Saxena RK.

Vaccine. 2008 Aug 18;26(35):4526-35. doi: 10.1016/j.vaccine.2008.06.031. Epub 2008 Jun 30.

PMID:
18590786
15.

Development of vaccines against falciparum malaria.

Ramalingam S, Mathai E.

Natl Med J India. 1996 May-Jun;9(3):120-4. Review.

PMID:
8664822
16.

Surface antigens of Plasmodium falciparum gametocytes--a new class of transmission-blocking vaccine targets?

Sutherland CJ.

Mol Biochem Parasitol. 2009 Aug;166(2):93-8. doi: 10.1016/j.molbiopara.2009.03.007. Epub 2009 Mar 28. Review.

PMID:
19450726
17.

Preclinical profiling of the immunogenicity of a two-component subunit malaria vaccine candidate based on virosome technology.

Okitsu SL, Mueller MS, Amacker M, Vogel D, Westerfeld N, Robinson JA, Zurbriggen R, Pluschke G.

Hum Vaccin. 2008 Mar-Apr;4(2):106-14. Epub 2007 Oct 18.

PMID:
18382133
18.

[Malaria vaccines: why, who and how?].

Hommel M.

Med Trop (Mars). 1995;55(4 Suppl):47-51. Review. French.

PMID:
8649266
19.

The hope but challenge for developing a vaccine that might control malaria.

Good MF.

Eur J Immunol. 2009 Apr;39(4):939-43. doi: 10.1002/eji.200939390.

20.

Supplemental Content

Support Center